Wide Ranks

AZTR

Azitra Inc

0.5194

Top Statistics
Market Cap 3 M Forward PE -0.5467 Revenue Growth 0.00 %
Current Ratio 5.58 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.2400 Enterprise / Revenue -27.24 Price To Sales Trailing12 Months 40.63
Profitability
Profit Margins 0.00 % Operating Margins -11474.17 %
Balance Sheet
Total Cash 7 M Total Cash Per Share 0.9520 Total Debt 643348
Total Debt To Equity 7.98 Current Ratio 5.58 Book Value Per Share 1.06
All Measures
Short Ratio 122.00 % Message Board Id finmb_404021170 Shares Short Prior Month 237661
Return On Equity -1.35 City Branford Uuid e7445f64-9918-3241-b1f1-a0f95f2c4b08
Previous Close 0.4947 First Trade Date Epoch Utc 1 B Book Value 1.06
Total Debt 643348 Volume 107342 Price To Book 0.4914
Last Split Date 1 B Fifty Two Week Low 0.4260 Total Cash Per Share 0.9520
Total Revenue 97500 Shares Short Previous Month Date 1 B Target Median Price 3.50
Max Age 86400 Recommendation Mean 2.00 Sand P52 Week Change 0.3133
Operating Margins -11474.17 % Target Mean Price 3.50 Net Income To Common -9028144
Ask 0.4930 Short Percent Of Float 0.0391 Implied Shares Outstanding 7 M
Last Fiscal Year End 1 B Trailing Peg Ratio None Average Daily Volume10 Day 145010
Average Volume10days 145010 Total Cash 7 M Next Fiscal Year End 1 B
Revenue Per Share 0.0490 Held Percent Insiders 0.0997 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.4947
Target Low Price 3.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.5175
Open 0.4969 Free Cashflow -6557838 State CT
Dividend Yield 0.00 % Return On Assets -0.8098 Time Zone Short Name EST
Trailing Eps -111.24 Day Low 0.4802 Address1 21 Business Park Drive
Shares Outstanding 7 M Price Hint 4 Target High Price 4.00
Website https://azitrainc.com 52 Week Change -0.9834 Average Volume 230389
Forward Eps -0.5200 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 531.50 % Last Split Factor 1:30 Regular Market Day High 0.5197
Is_sp_500 False Profit Margins 0.00 % Debt To Equity 7.98
Fifty Two Week High 68.40 Day High 0.5197 Shares Short 272941
Regular Market Open 0.4969 Industry Key biotechnology Bid 0.4825
Earnings Growth 0.00 % Enterprise To Revenue -27.24 Revenue Growth 0.00 %
Shares Percent Shares Out 0.0358 Operating Cashflow -10180952 Currency USD
Time Zone Full Name America/New_York Market Cap 3 M Is_nasdaq_100 False
Zip 06405 Quote Type EQUITY Industry Biotechnology
Long Name Azitra, Inc. Regular Market Day Low 0.4802 Held Percent Institutions 0.0182
Current Price 0.5194 Enterprise To Ebitda 0.2400 Financial Currency USD
Current Ratio 5.58 Gross Margins 100.00 % Industry Disp Biotechnology
Number Of Analyst Opinions 2 Country United States Float Shares 6 M
Two Hundred Day Average 3.38 Enterprise Value -2655912 Price To Sales Trailing12 Months 40.63
Forward PE -0.5467 Regular Market Volume 107342 Ebitda -11057098
Exchange ASE
Go to Yahoo Finance Go to Seeking Alpha 
Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

It develops ATR-12, a genetically modified strain of S.

epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.

The company also develops ATR-04, a genetically modified strain of S.

epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease.

It has a collaboration with Bayer.

The company was incorporated in 2014 and is based in Branford, Connecticut.